nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Beyond classical meta-analysis: can inadequately reported studies be included?
|
Robertson, Chris |
|
2004 |
9 |
21 |
p. 924-931 8 p. |
artikel |
2 |
Enhancing transdermal drug transport with low-frequency ultrasound
|
Ng, Ka-Yun |
|
2004 |
9 |
21 |
p. 913- 1 p. |
artikel |
3 |
Gene expression analysis enriched
|
Kriete, Andres |
|
2004 |
9 |
21 |
p. 913-914 2 p. |
artikel |
4 |
Hans Küpper discusses science and venture capital
|
Küpper, Hans |
|
2004 |
9 |
21 |
p. 909-912 4 p. |
artikel |
5 |
Microarray applications: emerging technologies and perspectives
|
Mathias, Gebauer |
|
2004 |
9 |
21 |
p. 915-917 3 p. |
artikel |
6 |
Monitor – biology
|
Spitzer, Eric |
|
2004 |
9 |
21 |
p. 941-943 3 p. |
artikel |
7 |
Monitor – business
|
Carey, Jayne |
|
2004 |
9 |
21 |
p. 943- 1 p. |
artikel |
8 |
Monitor – chemistry
|
Westwell, Andrew D. |
|
2004 |
9 |
21 |
p. 940-941 2 p. |
artikel |
9 |
Monitor – people
|
Carey, Jayne |
|
2004 |
9 |
21 |
p. 944- 1 p. |
artikel |
10 |
Quality: an old solution to new discovery dilemmas?
|
Volsen, Stephen G. |
|
2004 |
9 |
21 |
p. 903-905 3 p. |
artikel |
11 |
Stapled peptide induces cancer cell death
|
Whelan, Jo |
|
2004 |
9 |
21 |
p. 907- 1 p. |
artikel |
12 |
Strategies for designing clinical trials for oligonucleotide therapeutics
|
Wacheck, Volker |
|
2004 |
9 |
21 |
p. 918-923 6 p. |
artikel |
13 |
Sulforaphane halts breast cancer cell growth
|
Johnston, Nicole |
|
2004 |
9 |
21 |
p. 908- 1 p. |
artikel |
14 |
Targeting JNK3 for the treatment of neurodegenerative disorders
|
Resnick, Lynn |
|
2004 |
9 |
21 |
p. 932-939 8 p. |
artikel |
15 |
Zebularine: a candidate for epigenetic cancer therapy
|
Bradbury, Jane |
|
2004 |
9 |
21 |
p. 906-907 2 p. |
artikel |